| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/0005-2760(75)90005-3 |
| P953 | full work available at URL | https://api.elsevier.com/content/article/PII:0005276075900053?httpAccept=text/xml |
| https://api.elsevier.com/content/article/PII:0005276075900053?httpAccept=text/plain | ||
| P698 | PubMed publication ID | 1120140 |
| P2093 | author name string | J. I. Germershausen | |
| M. D. Greenspan | |||
| R. Mackow | |||
| P2860 | cites work | Journal of Pharmacology and Experimental Therapeutics | Q1500272 |
| Molecular Pharmacology | Q1943386 | ||
| Fatty acid activation and acyl transfer in rat liver during clofibrate feeding | Q70037458 | ||
| Inhibition of lipogenesis in rat liver by (-)-hydroxycitrate | Q70378538 | ||
| Liver acetyl-coenzyme-A carboxylase. Studies on kynurenate inhibition, isotope exchange and interaction of the uncarboxylated enzyme with citrate | Q70732130 | ||
| Insulin-like activity of dilute human serum assayed by an isolated adipose cell method | Q72724361 | ||
| FURTHER OBSERVATIONS ON THE EFFECTS OF ATROMID AND OF ETHYL CHLOROPHENOXYISOBUTYRATE ON SERUM LIPID LEVELS | Q76672296 | ||
| REDUCTION OF SERUM CHOLESTEROL AND LIPIDS BY ETHYL CHLOROPHENOXYISOBUTYRATE | Q76672302 | ||
| A simple efficient liquid scintillator for counting aqueous solutions in a liquid scintillation counter | Q114837163 | ||
| Modification of metabolism and distribution of lipids by ethyl chlorophenoxyisobutyrate | Q34252821 | ||
| Effect of Halofenate and Clofibrate on Growth and Lipid Synthesis in Saccharomyces cerevisiae | Q40289629 | ||
| The regulation of glyceride synthesis in isolated white-fat cells. The effects of acetate, pyruvate, lactate, palmitate, electron-acceptors, uncoupling agents and oligomycin | Q42918737 | ||
| Clofibrate and nafenopin (SU-13437): effects on plasma clearance and tissue distribution of chylomicron triglyceride in the dog. | Q51679430 | ||
| Clinical evaluation of MK-185: A new hypolipidemic drug | Q54450833 | ||
| Metabolic studies in isolated rat liver cells. I. Lipid synthesis | Q68480013 | ||
| Effect of ethyl p-chlorophenoxyisobutyrate on rat adipose lipoprotein lipase activity | Q68607937 | ||
| Influence of free fatty acid concentration on drug binding to plasma albumin | Q69035406 | ||
| The action mechanism of cerulenin. I. Effect of cerulenin on sterol and fatty acid biosynthesis in yeast | Q69204010 | ||
| Inhibition of fatty acid synthetases by the antibiotic cerulenin | Q69375664 | ||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | biochemistry | Q7094 |
| biophysics | Q7100 | ||
| endocrinology | Q162606 | ||
| adipocyte | Q357519 | ||
| P304 | page(s) | 190-8 | |
| P577 | publication date | 1975-02-20 | |
| P1433 | published in | Biochimica et Biophysica Acta | Q864239 |
| P1476 | title | Effect of halofenate and clofibrate on lipid synthesis in rat adipocytes | |
| P478 | volume | 380 |
| Q39145733 | Comparative effects of (−)-hydroxycitrate and (+)-allo-hydroxycitrate on acetyl CoA carboxylase and fatty acid and cholesterol synthesis in vivo |
| Q42528941 | Cross-Species Differential Plasma Protein Binding of MBX-102/JNJ39659100: A Novel PPAR-gamma Agonist |
| Q40879025 | Effects of Halofenate on Glucose Tolerance in Patients with Hyperlipoproteinemia |
| Q52496546 | Halofenate and clofibrate inhibition of pyruvate dehydrogenase from Fusarium culmorum. |
| Q39120966 | Hepatic triglyceride lipases—Effect of clofibrate and halofenate |
| Q67542730 | Hupolipidemic activity of (--)-hydroxycitrate |
| Q39722056 | Hyperlipidemia in primary gout |
| Q70994585 | Metabolic pathways involved in lipogenesis from lactate and acetate in bovine adipose tissue: Effects of metabolic inhibitors |
| Q39163598 | Reduced activity of hepatic microsomal fatty acid chain elongation synthesis in clofibrate-fed rats |
| Q40746608 | Studies on the mechanism of action of halofenate |
| Q59651013 | The NADPH consumption regulates the NADPH-producing pathways (pentose phosphate cycle and malic enzyme) in rat adipocytes |
| Q40119289 | p-Chlorophenoxyisobutyrate enhanced retention of homologous lipoproteins by human aortic smooth muscle cells |
Search more.